Qiagen NV | QIA - 流动负债

金融业

USD

USD 6.3B

现金及等价物

USD 839.01M

USD 217.43M

USD 2B

USD 512.14M

USD 1.81B

股息收益率

USD 0.56

USD 121.88M

USD 249.69M

USD 6.18K

EPS每股收益

USD 0.46

股本和储备

USD 3.78B

USD 325.27M

债务利息支出

USD 10.14M

USD 20M

USD 1.65B

USD 7.02B

USD 107.83M

USD 418.54M

USD 121.88M

普通股股本

USD 216.56M

20.54

USD 109.17M

USD 419.22M

销售和管理费用

USD 153.88M

USD 301.89M

贸易债权人

USD 72.66M

应收帐款人

USD 402.61M

	流动负债	更改		日
Akebia Therapeutics	USD 173.88M		10.95M	2026-03
Alaunos Therapeutics	USD 595K		218K	2026-03
argenx SE	USD 1.32B		278.28M	2025-12
Avita Medical	AUD 62.68M		77K	2025-12
Dianthus Therapeutics	USD 38.28M		7.55M	2026-03
Ionis Pharmaceuticals	USD 717M		66M	2026-03
IQVIA Holdings	USD 8.33B		9M	2026-03
Moderna	USD 2.4B		408M	2026-03
Organon & Co	USD 2.5B		110M	2026-03
Qiagen NV	USD 512.14M		461.26M	2025-12
Revvity	USD 1.24B		92.6M	2026-03
Tectonic Therapeutic	USD 12.96M		3.29M	2026-03
Viatris	USD 6.81B		284M	2026-03
Xeris Pharmaceuticals	USD 118.59M		9.02M	2026-03